The structure of the cyclodextrin complex. XV. Crystal structure of hexakis(2,3,6-tri-O-methyl)-.ALPHA.-cyclodextrin-p-nitrophenol(1:1)complex monohydrate.
スポンサーリンク
概要
- 論文の詳細を見る
The crystal structure of the hexakis(2,3,6-tri-<I>O</I>-methyl)-α-cyclodextrin (abbreviated to methyl-α-CDx) complex with <I>p</I>-nitrophenol, C<SUB>54</SUB>H<SUB>96</SUB>O<SUB>30</SUB>·C<SUB>6</SUB>H<SUB>5</SUB>NO<SUB>2</SUB>·H<SUB>2</SUB>O, was investigated by the X-ray method. The crystal is monoclinic, the space group being P2<SUB>1</SUB> with <I>Z</I>=2; the cell dimensions are <I>a</I>=11.307(1), <I>b</I>=14.578(1), <I>c</I>=22.118(2) Å, and β=93.62(1)°. The structure was determined by means of the Patterson map and the trial-and-error method combined with the rigid-body least-squares technique, and refined by the block-diagonal least-squares method to the final <I>R</I>-value of 0.048 for 4976 reflections (sinθ⁄λ<0.54). The methyl-α-CDx molecule has the shape of a truncated hexagonal cone, into which the <I>p</I>-nitrophenol molecule is inserted. The phenolic hydroxyl group is located at the center of the methyl-α-CDx cavity, while the nitro group protrudes outside from the base-side of the host cone and is in contact with the adjacent methyl-α-CDx molecule. The water molecule, which is also located within the cavity, links the methyl-α-CDx and <I>p</I>-nitrophenol molecules by hydrogen bonds. Methyl-α-CDx molecules are stacked along the crystallographic a axis in a heat-to-tail mode to form a channel-type structure.
- 公益社団法人 日本化学会の論文
著者
-
HARATA KAZUAKI
Research Institute for Polymer and Textiles
-
Hirayama Fumitoshi
Faculty Of Pharmaceutical Sciences Kumamoto University
-
Uekama Kaneto
Faculty Of Pharmaceutical Sciences Kumamoto University
-
Otagiri Masaki
Faculty Of Pharmaceutical Science Kumamoto University
関連論文
- Involvement of Lipid Rafts of Rabbit Red Blood Cells in Morphological Changes Induced by Methylated β-Cyclodextrins(Biopharmacy)
- Pseudorotaxane-Like Supramolecular Complex of Coenzyme Q10 with γ-Cyclodextrin Formed by Solubility Method
- Improved Stability of OPALMON^[○!R] Tablets under Humid Conditions IV : Effect of Polysaccharides and Disintegrants on the Stability and Dissolution Property of OPALMON^[○!R] Tablets
- Effects of Cyclodextrins on the Aggregation of Recombinant Human Growth Hormone (rhGH)
- A Moderate Interaction of Maltosyl-α-cyclodextrin with Caco-2 Cells in Comparison with the Parent Cyclodextrin
- Analysis of the Phase Solubility Diagram of a Phenacetin/Competitor/β-Cyclodextrin Ternary System, Involving Competitive Inclusion Complexation
- Hydrolysis Behavior of Prednisolone 21-Hemisuccinate/β-Cyclodextrin Amide Conjugate : Involvement of Intramolecular Catalysis of Amide Group in Drug Release
- Effects of Aging on Crystallization, Dissolution and Absorption Characteristics of Amorphous Tolbutamide-2-Hydroxypropyl-β-cyclodextrin Complex
- Inhibitory Effect of 2-Hydroxypropyl-β-cyclodextrin on the Foaming Generated by the Phosphodiester Compound of Vitamin C and E, EPC-K1
- Enhanced Absorption of Cyclosporin A be Complexation with Dimethyl-β-cyclodextrin in Bile Duct-Cannulated and -Noncannulated Rats
- Varying Effects of Cyclodextrin Derivatives on Aggregation and Thermal Behavior of Insulin in Aqueous Solution
- Spectroscopic Characterization of the Inclusion Complex of a Luteinizing Hormone-Releasing Hormone Agonist, Buserelin Acetate, with Dimethyl-β-cyclodextriin
- Preparation of Hydrophilic Nanoparticles of C_ with High Resistance to Aggregation during Storage, using 2-Hydroxypropyl-β-cyclodextrin
- Polypseudorotaxane Formation of Randomly-Pegylated Insulin with Cyclodextrins: Slow Release and Resistance to Enzymatic Degradation
- Prominent Inhibitory Effect of 2-Hydroxybutyl-β-cyclodextrin on Solution-mediated Polymorphic Transition of Chlorpropamide
- Enzymatic Hydrolysis of the Horn and Hoof of Cow and Buffalo
- Transparent, Adhesive Film Formation of Per-O-valeryl-β-cyclodextrin
- INCLUSION COMPLEXATIONS OF FLURBIPROFEN WITH β-CYCLODEXTRIN AND TRI-O-METHYL-β-CYCLODEXTRIN
- Interaction Mode of Dicumarol and Its Derivatives with Human Serum Albumin, α_1-Acid Glycoprotein and Asialo α_1-Acid Glycoprotein
- Catalytic Properties for Naphthoquinones and Partial Primary Structure of Rabbit Heart Acetohexamide Reductase
- Carbonyl Reductase Purified from Rabbit Liver Is Not the Product of a Carbonyl Reductase Gene (RCBR5 or RCBR6) Cloned from the Rabbit Liver cDNA Library
- Characterization of Acetohexamide Reductases Purified from Rabbit Liver, Kidney, and Heart: Structural Requirements for Substrates and Inhibitors
- Purifiation and Catalytic Properties of a Novel Acetohexamide-Reducing Enzyme from Rabbit Heart
- Stereoselective Reduction of Acetohexamide in Cytosol of Rabbit Liver
- Stability of a Cisplatin-Chondroitin Sulfate A Complex in Plasma and Kidney in Terms of Protein Binding
- Sex-Dependent Pharmacokinetics and in Vitro Reductive Metabolism of Acetohexamide in Wistar-Imamichi Rats
- Individual Variation of Acetohexamide Reductase Activities in Liver Microsomes and Cytosol of Rats
- Possible Enhancing Mechanism of the Cutaneous Permeation of 4-Biphenylylacetic Acid by β-Cyclodextrin Derivatives in Hydrophilic Ointment
- COMBINED USE OF CYCLODEXTRIN DERIVATIVES AND PENETRATION ENHANCER HPE-101 IN TRANSDERMAL DELIVERY OF PROSTAGLANDIN E_1
- High-performance liquid chromatography with chemiluminescence detection of penbutolol and its hydroxylated metabolite in rat plasma
- 2-Hydroxypropylated Cyclodextrins as a Sustained-Release Carrier for Fragrance Materials
- Effects of Repeated Clarithromycin Administration on the Pharmacokinetic Properties of Pindolol in Rats
- Effects of α_1-Acid Glycoprotein on Erythrocyte Deformability and Membrane Stabilization(Biopharmacy)
- Characterization of Ligand Binding Sites on the α_1-Acid Glycoprotein in Humans, Bovines and Dogs
- EFFECT OF REPEATED ADMINISTRATION OF PYRIDINOLCARBAMATE ON THE RENAL EXCRETION OF SOME DRUGS IN RABBITS
- Characterization of a Binding Site of UCN-01,a Novel Anticancer Drug on α_1-Acid Glycoprotein
- Inclusion Complex of 3,9-Bis(N, N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with Heptakis(2,6-di-O-methyl)-β-cyclodextrin : Interaction and Dissolution Properties
- Effect of Grinding with Hydroxypropyl Cellulose on the Dissolution and Particle Size of a Poorly Water-Soluble Drug
- Inhibitory Effects of Flavonoids on Rabbit Heart Carbonyl Reductase
- Inhibition of Rabbit Heart Carbonyl Reductase by Fatty Acids
- Purification and Catalytic Properties of a Tetrameric Carbony1 Reductase from Rabbit heart
- STUDIES ON BEFUNOLOL REDUCTASE FROM RABBIT LIVER
- In Vivo and in Vitro Binding of (-)-Hydroxyhexamide, a Major Metabolite of Acetohexamide, to Rabbit Serum
- Metabolic Reduction of Acetohexamide in Rat Kidney : Sex Difference and Effect of Streptozotocin-Induced Diabetes
- SEX DIFFERENCE OF ACETOHEXAMIDE REDUCTION IN RAT LIVER
- EFFECTS OF VARIOUS FACTORS ON METABOLIC REDUCTION OF ACETOHEXAMIDE
- REDUCTION OF ACETOHEXAMIDE BY RABBIT HEART CYTOSOL
- Effect of Phenylbutazone on Serum Protein Binding and Pharmacokinetic Behavior of Sulfadimethoxine in Rabbits, Dogs and Rats
- SPECIES DIFFERENCE IN PROTEIN BINDING DISPLACEMENT OF SULFADIMETHOXINE
- EFFECT OF PHENYLBUTAZONE ON SERUM PROTEIN BINDING OF SULFADIMETHOXINE IN DIFFERENT ANIMAL SPECIES
- ALLEVIATION OF CHLORPROMAZINE-PHOTOSENSITIZED CONTACT DERMATITIS BY β-CYCLODEXTRIN DERIVATIVES AND THEIR POSSIBLE MECHANISMS
- REDUCTION IN PHOTOTOXICITY OF DRUGS BY CYCLODEXTRIN COMPLEXATIONS AND ITS POSSIBLE MECHANISM
- MODEL ANALYSIS OF INTERFACIAL TRANSFER AND ABSORPTION BEHAVIOR OF DRUG FOLLOWING DISSOLUTION FROM COMPRESSED TABLET : IN THE CASES OF SULFONAMIDES AND β-CYCLODEXTRIN COMPLEXES
- IMPROVEMENT OF ORAL BIOAVAILABILITY OF PREDNISOLONE BY β-CYCLODEXTRIN COMPLEXATION IN HUMANS
- ENHANCED ORAL BIOAVAILABILITY OF ANTIINFRAMMATORY DRUG FLURBIPROFEN IN RABBITS BY TRI-O-METHYL-β-CYCLODEXTRIN COMPLEXATION
- IMPROVEMENTS OF SOME PHARMACEUTICAL CHARACTERISTICS OF VARIOUS STEROIDAL DRUGS BY CYCLODEXTRIN COMPLEXATION
- Pharmaceutical Evaluation of Hydroxyalkylated β-Cyclodextrin Derivatives
- REDUCTION IN THE LOCAL TISSUE TOXICITY OF CHLORPROMAZINE BY β-CYCLODEXTRIN COMPLEXATION
- Study of Interaction of Pranoprofen with Human Serum Albumin : Binding Properties of Enantiomers and Metabolite
- ENANTIOSELECTIVE ORAL BIOAVAILABILITY OF O-ISOVALERYL PROPRANOLOL AS A POTENTIAL PRODRUG OF PROPRANOLOL
- Interaction of Fluorescent Probe 7-Anilino-4-methylcoumarin-3-(p)-benzoic Acid with Egg Albumin
- ENHANCED BIOAVAILABILITY OF DIGOXIN BY γ-CYCLODEXTRIN COMPLEXATION
- Potential Use of 2-Hydroxypropyl-β-cyclodextrin for Preparation of Orally Disintegrating Tablets Containing dl-α-Tocopheryl Acetate, an Oily Drug
- Preparation of Four Types of Coenzyme Q10/γ-Cyclodextrin Supramolecular Complexes and Comparison of Their Pharmaceutical Properties
- Combination Effects of α-Cyclodextrin and Xanthan Gum on Rectal Absorption and Metabolism of Morphine from Hollow-Type Suppositories in Rabbits
- REDUCTION IN THE LOCAL TOXICITY OF CHLORPROMACINE AND ITS PHOTOPRODUCTS BY CYCLODEXTRIN COMPLEXATION
- PROTECTIVE MECHANISM OF β-CYCLODEXIRIN FOR THE HEMOLYSIS INDUCED WITH PHENOTHIAZINE NEUROLEPTICS IN VITRO
- CYCLODEXTRIN-INDUCED HEMOLYSIS AND SHAPE CHANGES OF HUMAN ERYTHROCYTES IN VITRO
- PROTECTIVE EFFECTS OF CYCLODEXTRINS ON THE HEMOLYSIS INDUCED WITH TRANQUILIZING PHENOTHIAZINES
- PROTECTIVE EFFECTS OF CYCLODEXTRINS ON DRUG-INDUCED HEMOLYSIS IN VITRO
- PROTECTION AGAINST THE PHOTOSENSITIZED SKIN IRRITANCY OF CHLORPROMAZINE BY CYCLODEXTRIN COMPLEXATION
- EFFECTS OF CYCLODEXTRINS ON THE PHOTOLYSES OF TRAN-QUILIZING PHENOTHIAZINES IN AQUEOUS SOLUTION
- Nanomolar Quantification and Identification of Various Nitrosothiols by High Performance Liquid Chromatography Coupled with Flow Reactors of Metals and Griess Reagent
- Enhanced Dissolution of Poorly Water-Soluble Drugs by Water-Soluble Gelatin
- THE ROLE OF SERUM PROTEIN BINDING IN THE INTESTINAL ABSORPTION OF DRUGS
- MODEL ANALYSES OF INTERFACIAL TRANSFER AND ABSORPTION BEHAVIORS OF DRUGS FOLLOWING DISSOLUTION : APPROACH TO EVALUATION PROCEDURE OF BIOAVAILABILITY
- Opposite Effects of Metoclopramide and Propantheline on Intestinal Absorption of Imipramine in Rats
- INTERACTION OF WARFARIN WITH HUMAN SERUM ALBUMIN
- IMPROVEMENT OF CHEMICAL STABILITY OF PROSTAGLANDINS BY INCLUSION COMPLEXATION WITH METHYLATED CYCLODEXTRINS AND THEIR STABILIZATION MECHANISM
- EFFECTS OF β- AND γ-CYCLODEXTRINS ON THE PHARMACOKINETIC BEHAVIOR OF PREDNISOLONE AFTER INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATIONS TO RABBITS
- The Circular Dichroism Spectra of the β-Cyclodextrin Complex with Naphthalene Derivatives
- The structure of the cyclodextrin complex. VII. The crystal structure of the .ALPHA.-cyclodextrin-DMSO-methanol(1:1:2) dihydrate complex A simultaneous inclusion of DMSO and methanol.
- Temperature effects on CD spectra of .ALPHA.-cyclodextrin complexes with m- and p-nitrophenol.
- The structure of the cyclodextrin complex. II. The crystal structure of .ALPHA.-cyclodextrin-methyl orange (2:1) complex.
- Temperature effects on CD spectra of .BETA.-cyclodextrin complexes with 2-substituted naphthalenes.
- The structure of the cyclodextrin complex. IV. The crystal structure of .ALPHA.-cyclodextrin-sodium 1-propanesulfonate nonahydrate.
- The Structure of the Cyclodextrin Complex. I. The Crystal and Molecular Structure of the α-Cyclodextrin– p-Iodoaniline Complex
- The structure of the cyclodextrin complex. V. Crystal structures of .ALPHA.-cyclodextrin complexes with p-nitrophenol and p-hydroxybenzoic acid.
- Activity coefficients of dimethyl-.BETA.-cyclodextrin in aqueous solutions.
- The structure of the cyclodextrin complex. XI. Crystal structure of hexakis-(2,3,6-tri-o-methyl)-.ALPHA.-cyclodextrin-p-iodoaniline monohydrate.
- The structure of the cyclodextrin complex. XIV. Crystal structure of hexakis(2,3,6-tri-O-methyl)-.ALPHA.-cyclodextrin-benzaldehyde (1:1) complex.
- Micellar effects on base-catalyzed isomerization of prostaglandin A1 and prostaglandin A2.
- The structure of the cyclodextrin complex. XVIII. Crystal structure of .BETA.-cyclodextrin-benzyl alcohol (1:1) complex pentahydrate.
- The structure of the cyclodextrin complex. XV. Crystal structure of hexakis(2,3,6-tri-O-methyl)-.ALPHA.-cyclodextrin-p-nitrophenol(1:1)complex monohydrate.
- The structure of the cyclodextrin complex. XIX Crystal structures of hexakis(2,3,6-tri-O-methyl)-.ALPHA.-cyclodextrin complexes with (S)- and (R)-mandelic acid. Chiral recognition through the induced-fit conformational change of the macrocyclic ring.
- The structure of the cyclodextrin complex. X. Crystal structure of .ALPHA.-cyclodextrin-benzaldehyde (1:1) complex hexahyderate.
- The structure of the cyclodextrin complex. XVI. Crystal structure of heptakis(2,3,6-tri-O-methyl)-.BETA.-cyclodextrin-p-iodophenol(1:1) complex tetrahydrate.
- The structure of the cyclodextrin complex. XVII. Crystal structure of .BETA.-cyclodextrin-hexamethylenetetramine (1:1) complex hexahydrate.
- The structure of the cyclodextrin complex. XXII. Crystal structures of hexakis(2,6-di-O-methyl)-.ALPHA.-cyclodextrin complexes with 1-propanol and iodine. Evidence for the formation of iodine-host charge-transfer complex.